Covid 19 Insurance Plans

The Covid-19 pandemic created one of the most significant demand surges for health insurance that India's insurance market had ever experienced. The combination of rapid hospitalisation volumes, high treatment costs particularly for severe cases requiring ICU care and oxygen support, and the widespread recognition among previously uninsured households that a single health event could create financially catastrophic medical bills drove unprecedented interest in health insurance products during 2020, 2021, and 2022.

In response to this demand, IRDAI mandated that all health insurance policies must cover Covid-19 hospitalisation as a standard disease, and additionally instructed insurers to develop specific Covid-specific insurance products to address the acute demand from households seeking protection during the pandemic period.

This guide explains how Covid-19 insurance evolved in India, what specific Covid products were introduced, how the coverage landscape looks today as the acute pandemic phase has passed, and what the best approach to protecting against infectious disease hospitalisation costs is for Indian households in the current environment.

How Covid-19 Became Covered Under Standard Health Insurance

When Covid-19 emerged as a widespread disease in India in early 2020, the initial question for health insurance policyholders was whether their existing health insurance policies covered Covid-19 hospitalisation. IRDAI moved quickly to clarify and mandate this: in April 2020, IRDAI issued a circular directing all licensed health and general insurers to cover Covid-19 hospitalisation under their standard health insurance policies without any exclusion based on the pandemic or epidemic nature of the disease.

This regulatory direction meant that for any Indian who already held a standard health insurance policy, Covid-19 hospitalisation treatment costs including hospital room charges, ICU costs, doctor fees, medications, and diagnostic tests during hospitalisation were covered under their existing policy, subject to the standard terms including any applicable waiting periods for other conditions.

For households that did not have any health insurance at the time of the pandemic, the acute awareness of the financial risk drove new policy purchases. However, standard health insurance policies have an initial waiting period of typically thirty to ninety days before any hospitalisation claim is admissible, meaning households that bought insurance only after contracting Covid-19 or during an active wave would have faced this waiting period challenge.

Corona Kavach: IRDAI's Standardised Covid Health Insurance Product

To address the specific need for Covid-19 insurance coverage that could be accessed quickly and at affordable premiums, IRDAI introduced a standardised Covid-specific health insurance product called Corona Kavach in 2020. This product was mandated to be offered by all licensed general and health insurers at standardised terms that IRDAI specified.

Corona Kavach was an indemnity-based product that covered the hospitalisation costs for Covid-19 treatment on a cashless or reimbursement basis. The policy covered a range of Covid-19-related treatment costs including hospital room charges, ICU costs, nursing expenses, doctor fees, medicines, diagnostic tests, and in some configurations Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy treatments for Covid-19.

The product was available at short tenure options of three and a half, six and a half, and nine and a half months rather than the standard annual policy tenure, recognising that buyers during the pandemic wanted short-duration coverage at a time when the trajectory of the pandemic was uncertain. The sum insured options ranged from fifty thousand rupees to five lakh rupees.

As a IRDAI-standardised product, Corona Kavach had identical coverage structure across all participating insurers, with premium being the primary point of difference between insurers.

Corona Rakshak: A Benefit-Based Complement to Corona Kavach

Alongside the indemnity-based Corona Kavach, IRDAI also introduced Corona Rakshak, a benefit-based or lump sum Covid-specific product. While Corona Kavach reimbursed actual hospitalisation costs up to the sum insured, Corona Rakshak paid a fixed lump sum upon the policyholder's positive diagnosis of Covid-19 with a minimum continuous hospitalisation of seventy-two hours.

The benefit-based structure of Corona Rakshak was designed to address the income disruption and non-hospitalisation costs that Covid-19 created for affected households, including the costs of home quarantine, lost income during isolation, and other financial impacts not captured by hospitalisation cost reimbursement alone.

Both Corona Kavach and Corona Rakshak were designed as pandemic-period products. Their availability and renewal terms were subject to IRDAI's ongoing regulatory direction as the pandemic evolved.

The Current Status: How Covid Coverage Works Under Standard Health Insurance

As India has moved through the acute pandemic phase and Covid-19 has become an endemic disease rather than an acute epidemic emergency, the dedicated Covid-specific insurance products launched during the pandemic have largely been discontinued or have not been renewed as active mainstream products.

For current health insurance buyers, the relevant question is how Covid-19 hospitalisation is covered under standard health insurance policies. The answer is that under the IRDAI regulatory direction that mandated Covid-19 coverage in standard health insurance, Covid-19 hospitalisation is covered as a standard disease under any valid health insurance policy that covers general hospitalisation.

A standard comprehensive health insurance policy purchased today from any licensed health or general insurer will cover hospitalisation for Covid-19 or any other infectious disease in the same way as hospitalisation for any other covered medical condition. The hospitalisation coverage includes room charges, ICU costs, doctor fees, medications, and diagnostic tests during the hospitalisation period.

For post-Covid complications, the coverage depends on the specific nature of the complication and whether it meets the hospitalisation requirements of the policy. Conditions requiring hospital admission for covered treatment are covered. Ongoing management of post-Covid conditions on an outpatient basis is not covered under standard hospitalisation insurance.

What the Best Covid Insurance Approach Is Today

For households currently evaluating their protection against Covid-19 and similar infectious disease hospitalisation costs, the best approach is holding a comprehensive standard health insurance policy rather than seeking a dedicated Covid-specific product.

A standard health insurance policy with an adequate sum insured, typically five lakh rupees or above for individuals and ten lakh rupees or above for families in metro areas, provides coverage for hospitalisation from any medical condition including Covid-19, influenza requiring hospitalisation, dengue, malaria, and any other infectious disease that results in inpatient treatment.

The advantages of this approach over a dedicated Covid-specific product are significant. Standard health insurance covers a broad range of medical conditions, not just Covid-19, so the premium provides protection against the full spectrum of hospitalisation risks rather than a single disease. Standard health insurance can be renewed annually and builds accumulated waiting period credits over time for pre-existing conditions. It is available from a wide range of licensed insurers at competitive premiums with cashless hospital networks.

For households that currently hold no health insurance, acquiring a standard comprehensive health insurance policy is the most effective way to gain protection against Covid-19 hospitalisation costs and all other medical hospitalisation risks simultaneously.

The Lessons of Covid-19 for Health Insurance Awareness

The Covid-19 pandemic created a lasting shift in health insurance awareness among Indian households. The experience of seeing peers and family members face hospitalisation costs of lakhs of rupees for Covid treatment, the real-world evidence of how health insurance prevented financial catastrophe for insured households while uninsured households faced financial devastation, and the widespread media coverage of the financial dimension of the pandemic collectively produced the most significant increase in health insurance awareness and new policy acquisition in India's insurance history.

For households that are now in the post-pandemic period considering whether health insurance remains relevant, the pandemic provides the clearest possible evidence of the answer. Health insurance is the mechanism that prevents a hospitalisation event from creating a financial catastrophe. Covid-19 demonstrated this at scale. The next infectious disease outbreak, or the next hospitalisation from any cause, represents the same financial risk that Covid-19 made so visible.

Maintaining and adequately sizing health insurance coverage in the post-pandemic period is the most important financial protection action for Indian households, building on the awareness the pandemic created rather than allowing that awareness to fade now that the acute emergency has passed.

Key Features to Look for in Health Insurance That Covers Infectious Disease

For households evaluating health insurance with infectious disease hospitalisation coverage in mind, several specific features deserve attention.

Coverage for communicable diseases should be verified in the policy terms. IRDAI's direction mandates Covid-19 coverage, and standard health insurance covers hospitalisation from any covered illness. The policy should not include a specific exclusion for epidemic or pandemic-related diseases beyond any initial waiting period.

The initial waiting period should be noted. Standard health insurance policies have an initial waiting period of typically thirty to ninety days from policy inception during which no illness-related hospitalisation claims are admissible. An individual who buys health insurance after an infectious disease outbreak has already begun may face this waiting period before coverage activates.

Daycare treatment coverage is relevant for infectious diseases that may be managed with outpatient infusions or short-stay treatments that do not require twenty-four-hour hospitalisation. Plans that cover daycare procedures include these shorter-stay treatments.

Home treatment or domiciliary hospitalisation coverage is relevant for infectious diseases where the treating physician recommends home isolation and treatment rather than hospital admission. Plans with domiciliary hospitalisation coverage include home treatment costs when medically certified as a substitute for hospitalisation.

Exploring Health Insurance Options on Stashfin

Stashfin provides access to health insurance plan options from licensed insurers that include standard coverage for hospitalisation from infectious diseases including Covid-19. Exploring what is available through the Stashfin app or website is a practical starting point for households assessing their health insurance coverage in the post-pandemic environment.

Insurance products are subject to IRDAI regulations and policy terms. Please read the policy document carefully before purchasing. Stashfin acts as a referral partner only.